Elsa Rossignol, M.D., F.R.C.P., F.A.A.P.

Former Postdoctoral Fellow

Elsa Rossignol

Current Position

Associate Professor University of Montreal
Pediatric Neurologist
Hopital Ste-Justine, Research Center, lab A-706
3175 Ch Cote-Ste-Catherine
Montreal, Quebec, Canada, H3T 1C5

Contact Information

Phone: 514.345.4931 ext:7241
Emailelsarossignol@hotmail.com
Websitehttp://www.chu-sainte-justine.org/

Education and Training

Undergraduate/Graduate

  • 2007-2011: Postdoctoral Fellow, Gordon Fishell Lab, Neuroscience Institute, NYU School of Medicine, NY
  • 2007: Fellowship in Clinical Neurogenetics and Medical Genetics, Université de Montréal, Hôpital Sainte-Justine
  • 2005-2007: Masters in Neuroscience (Neurogenetics), "Clinical and genetic characterization of hereditary congenital myotonia in French Canadians: new mutations and founder effects", Research director: Dr. Bernard Brais, Department of Neurology, CHUM (U of Montreal) and Center for Neurosciences, Department of Physiology, U of Montreal
  • 2003-2007: Pediatric Neurology (Residency), Université de Montréal, Hôpital Sainte-Justine, Canadian Royal College Boards of Neurology (FRCP) 05/2007
  • 2000-2003: Pediatrics (Residency), Université de Montréal, Hôpital Sainte-Justine, American Boards of Paediatrics (ABP) 09/2004, Canadian Royal College Boards of Paediatrics (FRCP) 05/2004
  • 1995-2000: Medicine (MD-CM), McGill University, Montreal

Previous Work

As a pediatric neurologist, I have developed strong interests in studying the molecular basis of neurodevelopmental disorders including autism, mental retardation and epilepsy. Unfortunately, the causes for these disorders remain poorly defined in most cases and available treatments remain non-specific and sub-optimal. As dysfunctions of cortical interneurons are felt to be involved in these conditions, studying animal models of genetic anomalies in interneuron development will hopefully shed light on the physiopathology underlying these developmental disorders in humans and eventually lead to better diagnosis and treatments for these patients.